This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Masashi Aonuma: Innovator in Anti-Tumor Compounds
Introduction
Masashi Aonuma is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that exhibit anti-tumor activity. His innovative work focuses on the interaction between critical proteins involved in cancer progression.
Latest Patents
Aonuma holds a patent for "Imidazothiazole derivatives having proline ring structure." This patent describes compounds that inhibit the interaction between murine double minute 2 (Mdm2) protein and p53 protein. The compounds developed by Aonuma demonstrate potential anti-tumor activity, making them valuable in cancer research and treatment.
Career Highlights
Masashi Aonuma is associated with Daiichi Sankyo Company, Limited, where he continues to advance his research in pharmaceutical innovations. His work has contributed to the understanding of protein interactions in cancer biology, paving the way for new therapeutic strategies.
Collaborations
Aonuma has collaborated with notable colleagues, including Kouichi Uoto and Yuuichi Sugimoto. These partnerships have enhanced the research efforts in developing effective anti-cancer compounds.
Conclusion
Masashi Aonuma's contributions to the field of medicinal chemistry, particularly through his patented compounds, highlight his role as an innovator in the fight against cancer. His work continues to inspire advancements in therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile